EI
TEVA icon

Ellevest Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Ellevest Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-163
Closed -$1K – 1352
2020
Q3 		$1K Sell
163
-15
-8% -$159 ﹤0.01% 1067
2020
Q2 		$2K Buy
178
+15
+9% +$170 ﹤0.01% 917
2020
Q1 		$1K Buy
163
+124
+318% +$1.27K ﹤0.01% 985
2019
Q4 		$0 Buy
+39
New +$348 ﹤0.01% 1048

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Ellevest Inc's TEVA Position: Q4 2020 in Review

Ellevest Inc sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 163 shares — an estimated $1K sold.

Ellevest Inc first reported a position in TEVA in Q4 2019 and held it in 4 quarters. The position peaked at $2K in Q2 2020. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Ellevest Inc reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Ellevest Inc sold 163 Teva Pharmaceuticals shares in Q4 2020, an estimated $1K.
  • Ellevest Inc first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Ellevest Inc's Teva Pharmaceuticals position peaked at $2K in Q2 2020.
  • 449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.